Baxter Earns CE Mark for Syringe-Infusion System Post author:Sam Post published:May 21, 2020 Post category:Devices & Diagnostics Letter The device should be available in Europe, Australia and New Zealand in June. Source: Devices & Diagnostics Letter You Might Also Like U.S. to Pay Nearly $2 Billion for Pfizer-BioNTech COVID-19 Vaccine July 22, 2020 First Genetic Test for Fragile X Syndrome Cleared February 24, 2020 FDA Approves Immunomedic’s Breast Cancer Treatment Trodelvy April 23, 2020